Related Experiment Video
Updated: Jan 22, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer
1Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. ylu@utmem.edu
Abstract:
Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer deaths in American males today. Novel and effective treatment such as gene therapy is greatly desired. The early viral based gene therapy uses tissue-nonspecific promoters, which causes unintended toxicity to other normal tissues. In this chapter, we will review the transcriptionally regulated gene therapy strategy for prostate cancer treatment. We will describe the development of transcriptionally regulated prostate cancer gene therapy in the following areas: (1) Comparison of different routes for best viral delivery to the prostate; (2) Study of transcriptionally regulated, prostate-targeted viral vectors: specificity and activity of the transgene under several different prostate-specific promoters were compared in vitro and in vivo; (3) Selection of therapeutic transgenes and strategies for prostate cancer gene therapy (4) Oncolytic virotherapy for prostate cancer. In addition, the current challenges and future directions in this field are also discussed.
Insights
Transcriptionally regulated gene therapy offers a promising approach to treating prostate cancer by targeting tumor cells specifically. This strategy aims to improve treatment efficacy and reduce side effects associated with earlier gene therapy methods.
Area of Science:
- Oncology
- Gene Therapy
- Molecular Biology
Background:
- Prostate cancer is a leading cause of cancer death in American men.
- Current treatments lack specificity, leading to toxicity.
- Gene therapy presents a novel treatment avenue, but early methods had limitations.
Purpose of the Study:
- To review transcriptionally regulated gene therapy for prostate cancer.
- To explore advancements in prostate-targeted viral vector development.
- To discuss therapeutic strategies, including oncolytic virotherapy.
Main Methods:
- Comparison of viral delivery routes to the prostate.
- In vitro and in vivo evaluation of prostate-specific promoters for transgene expression.
- Selection of therapeutic genes and oncolytic viruses.
Main Results:
- Development of transcriptionally regulated, prostate-targeted viral vectors.
- Demonstration of specificity and activity of transgenes in prostate cancer models.
- Identification of effective therapeutic strategies and transgenes.
Conclusions:
- Transcriptionally regulated gene therapy shows potential for effective and specific prostate cancer treatment.
- Further research into viral delivery, promoter selection, and therapeutic agents is ongoing.
- Challenges and future directions in prostate cancer gene therapy are identified.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Gene Therapy

